Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clayton Harro
Johns Hopkins Bloomberg School of Public Health
Study Chair - David Schwartz
Johns Hopkins Bloomberg School of Public Health
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uab Aveg
Birmingham, Alabama, United States
- Jhu Aveg
Baltimore, Maryland, United States
- St. Louis Univ. School of Medicine Aveg
St Louis, Missouri, United States
- Univ. of Rochester Aveg
Rochester, New York, United States
- Vanderbilt Univ. Hosp. Aveg
Nashville, Tennessee, United States
- Uw - Seattle Aveg
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- 31 Aug 1999
- Last update posted
- 4 Nov 2021
- Registered enrollment
- 100
- Registry id
- NCT00000904
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.